These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Immunological diagnosis of the kidney allograft rejection reaction]. Drannik GN Urol Nefrol (Mosk); 1981; (5):64-71. PubMed ID: 6458144 [No Abstract] [Full Text] [Related]
8. [Some parameters of cellular immunity in renal transplantation after more than three years]. Di Padova F; Morandi E; Baldini L; Vallino F; Como G; Celega E Boll Ist Sieroter Milan; 1979 Jan; 57(6):765-73. PubMed ID: 399731 [TBL] [Abstract][Full Text] [Related]
9. ABO-incompatible renal transplantation at Tokyo Women's Medical University. Tanabe K; Tokumoto T; Ishida H; Toma H; Nakajima I; Fuchinoue S; Teraoka S Clin Transpl; 2003; ():175-81. PubMed ID: 15387109 [TBL] [Abstract][Full Text] [Related]
10. Active T and EA-rosette-forming cells in human cadaver renal allograft recipients. Sengar DP; Rashid A; Harris JE Clin Exp Immunol; 1979 Feb; 35(2):236-41. PubMed ID: 373936 [TBL] [Abstract][Full Text] [Related]
11. Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study. Joshi SS; Bishop MR; Lynch JC; Tarantolo SR; Abhyankar S; Bierman PJ; Vose JM; Geller RB; McGuirk J; Foran J; Bociek RG; Hadi A; Day SD; Armitage JO; Kessinger A; Pavletic ZS Cytotherapy; 2003; 5(6):542-52. PubMed ID: 14660050 [TBL] [Abstract][Full Text] [Related]
12. Immunological monitoring after organ transplantation: potential role of soluble CD30 blood level measurement. Truong DQ; Darwish AA; Gras J; Wieërs G; Cornet A; Robert A; Mourad M; Malaise J; de Ville de Goyet J; Reding R; Latinne D Transpl Immunol; 2007 Jun; 17(4):283-7. PubMed ID: 17493532 [TBL] [Abstract][Full Text] [Related]
13. Patterns of graft and patient survival following renal transplantation and evaluation of serum creatinine as a predictor of survival: a review of data collected from one clinical centre over 34 years. McEwan P; Baboolal K; Dixon S; Conway P; Currie CJ Curr Med Res Opin; 2005 Nov; 21(11):1793-800. PubMed ID: 16307700 [TBL] [Abstract][Full Text] [Related]
14. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant? Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907 [TBL] [Abstract][Full Text] [Related]
15. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients. Meng HL; Jin XB; Li XT; Wang HW; Lü JJ Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748 [TBL] [Abstract][Full Text] [Related]
16. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival. Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959 [TBL] [Abstract][Full Text] [Related]
17. The effect of race and ethnicity on kidney allograft outcome. Katznelson S; Gjertson DW; Cecka JM Clin Transpl; 1995; ():379-94. PubMed ID: 8794281 [TBL] [Abstract][Full Text] [Related]